For laboratory and research use only. Not for human consumption.
Pinealon 20mg lyophilized vial - US manufactured research peptideCertificate per batchFor laboratory and research use only

The catalog

Pinealon

Tripeptide bioregulator (EDR) studied for proposed neuroprotective and circadian regulatory properties. Part of Professor Khavinson’s four-decade bioregulator research program. US-manufactured. ISO 17025 certificate per batch.

Vial formatISO 17025 certificateHPLC purityMass-spec identity

For laboratory and research use only. Not for human consumption.

SourcingAudited U.S. and E.U. facilities. FDA-registered API trail.
IdentityConfirmed by mass spectrometry per batch.
PurityHPLC measured. Printed on the certificate.

FeelGood does not provide dosing guidance, administration instructions, or protocols. Products are supplied for laboratory and research use only and are not intended for human consumption.

The research

What the published literature examined.

Pinealon is a tripeptide bioregulator studied for its neuroprotective and circadian regulatory properties. It is part of Professor Khavinson’s four-decade program of bioregulator peptide research, with a proposed target in the pineal gland and central nervous system.

About the Compound

Pinealon is a synthetic tripeptide with the sequence Glutamic acid-Aspartic acid-Arginine (EDR, also written Glu-Asp-Arg). It is classified as a cytogen, a bioregulator proposed to interact directly with DNA to modulate gene expression in target tissues rather than acting through receptor-dependent pathways.

Pinealon was developed as part of Professor Khavinson’s research program at the Saint Petersburg Institute of Bioregulation and Gerontology. Published research has examined its proposed effects in neuroprotection, oxidative stress reduction in neural tissue, and circadian rhythm regulation. Research interest has also extended to visual system and retinal neuroprotection.

Research Areas

  • Neuroprotection. Animal studies have examined effects on neural tissue under oxidative stress conditions, with proposed mechanisms involving antioxidative gene expression modulation.
  • Circadian regulation. Research has examined effects on melatonin and serotonin production pathways in the pineal gland.
  • Retinal protection. Animal studies have investigated effects on retinal neurons under conditions of ischemia and oxidative damage.
  • Cognitive aging models. Studies in aging rodent models have examined effects on spatial memory and cognitive performance markers.

The research base is primarily from Khavinson’s group. Independent Western replication is limited. Human clinical data does not exist in published form.

Specifications

  • Compound: Pinealon
  • Sequence: Glu-Asp-Arg (EDR)
  • Molecular weight: 417.39 Da
  • Form: Lyophilized powder, sealed glass vial
  • Size: 20mg
  • Purity: ≥98% by HPLC, batch-verified
  • Identity: Mass spectrometry confirmation per batch
  • Endotoxin: LAL assay per batch, reported on COA
  • Storage: −20°C sealed; 4°C after reconstitution, used within 28 days
  • Manufacturing: United States
  • Testing: Independent ISO 17025-accredited laboratory, batch-specific
  • Shipping: Temperature-controlled with insulated packaging

The Standard

Every batch of FeelGood Pinealon is manufactured in the United States and tested by an independent ISO 17025-accredited laboratory before release. The certificate of analysis specific to your lot ships with the order.

Sold as a research chemical for laboratory and research purposes only. Not intended for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.

Findings summarized in neutral terms based on the published literature. Most of the cited research is preclinical. Sold for research use only.